Elixinol Global (EXL.AX) stock price, revenue, and financials

Elixinol Global market cap is $14.8 m, and annual revenue was $15.01 m in FY 2020

$14.8 M

EXL.AX Mkt cap, 20-May-2022

$4.8 M

Elixinol Global Revenue H1, 2021
Elixinol Global Gross profit (H1, 2021)2.9 M
Elixinol Global Net income (H1, 2021)-10.8 M
Elixinol Global EBITDA (H1, 2021)-7.5 M
Elixinol Global EBIT (H1, 2021)-8.3 M
Elixinol Global Cash, 30-Jun-202119 M
Elixinol Global EV-1.4 M
Get notified regarding key financial metrics and revenue changes at Elixinol GlobalLearn more
Banner background

Elixinol Global Revenue Breakdown

Embed Graph

Elixinol Global revenue breakdown by business segment: 100.0% from SALE OF NUTRACEUTICAL AND RELATED HEMP PRODUCTS

Elixinol Global Income Statement

Annual

AUDFY, 2018FY, 2019FY, 2020

Revenue

37.1m32.3m15.0m

Cost of goods sold

(17.2m)(15.1m)(8.3m)

Gross profit

20.3m17.4m7.3m

Operating expense total

(20.1m)(40.5m)(28.8m)

Depreciation and amortization

(803.0k)(63.9m)(77.4m)

EBITDA

(477.0k)(24.7m)(22.6m)

EBIT

(1.3m)(88.6m)(100.0m)

Interest expense

(138.0k)(49.0k)

Interest income

441.0k568.0k100.0k

Pre tax profit

(497.0k)(90.6m)(100.3m)

Income tax expense

(363.0k)7.5m(4.2m)

Net Income

(860.0k)(83.1m)(104.5m)

Half Year

AUDH1, 2019H1, 2020H1, 2021

Revenue

17.5m7.9m4.8m

Cost of goods sold

(9.2m)(4.9m)(2.3m)

Gross profit

8.3m3.2m2.9m

Operating expense total

(19.8m)(17.2m)(10.3m)

Depreciation and amortization

(999.0k)(70.9m)(813.0k)

EBITDA

(11.0m)(14.7m)(7.5m)

EBIT

(12.0m)(85.6m)(8.3m)

Interest expense

(55.0k)(43.0k)

Interest income

266.0k71.0k25.0k

Pre tax profit

(12.0m)(85.6m)(10.9m)

Income tax expense

2.2m(4.6m)55.0k

Net Income

(9.8m)(90.3m)(10.8m)

Elixinol Global Balance Sheet

Annual

AUDFY, 2018FY, 2019FY, 2020

Cash

42.9m20.2m27.7m

Accounts Receivable

2.9m1.1m996.0k

Prepaid Expenses

3.7m6.5m1.5m

Inventories

7.0m21.3m4.7m

Current Assets

57.0m51.4m35.4m

PP&E

6.0m12.7m2.5m

Goodwill

74.6m28.2m

Total Assets

154.4m121.1m42.5m

Accounts Payable

3.6m1.8m1.8m

Short-term debt

989.0k920.0k

Current Liabilities

7.2m6.0m5.0m

Long-term debt

340.0k3.7m1.8m

Non-Current Liabilities

3.5m3.7m1.8m

Total Debt

340.0k4.7m2.7m

Total Liabilities

10.7m9.7m6.8m

Common Stock

139.6m188.8m217.7m

Retained Earnings

(3.6m)(86.5m)(191.0m)

Total Equity

143.7m111.4m35.7m

Half Year

AUDH1, 2019H1, 2020H1, 2021

Cash

48.1m16.8m19.0m

Accounts Receivable

4.1m1.3m1.5m

Prepaid Expenses

1.7m

Inventories

20.0m8.9m2.0m

Current Assets

78.8m29.0m24.2m

PP&E

16.9m4.7m2.2m

Goodwill

75.4m

Total Assets

195.9m41.0m31.3m

Accounts Payable

4.2m3.4m2.2m

Short-term debt

936.0k1.2m892.0k

Current Liabilities

6.7m6.4m4.2m

Long-term debt

3.7m2.4m1.8m

Non-Current Liabilities

5.0m2.4m1.8m

Total Debt

4.7m3.5m2.7m

Total Liabilities

11.7m8.8m6.0m

Common Stock

187.2m198.6m217.6m

Retained Earnings

(12.8m)(176.8m)(201.9m)

Total Equity

184.2m32.2m25.2m

Elixinol Global Cash Flow

Annual

AUDFY, 2018FY, 2019FY, 2020

Net Income

(860.0k)(83.1m)(104.5m)

Depreciation and Amortization

824.0k2.8m3.2m

Accounts Receivable

(2.2m)1.5m709.0k

Inventories

(4.5m)(25.4m)(2.2m)

Accounts Payable

5.3m(1.5m)(435.0k)

Cash From Operating Activities

(5.3m)(51.1m)(22.6m)

Cash From Investing Activities

(8.5m)(17.9m)2.6m

Cash From Financing Activities

37.8m46.4m27.5m

Net Change in Cash

24.1m(22.5m)7.4m

Half Year

AUDH1, 2019H1, 2020H1, 2021

Net Income

(9.8m)(90.3m)(10.8m)

Depreciation and Amortization

999.0k1.3m813.0k

Cash From Operating Activities

(28.9m)(15.2m)(8.0m)

Cash From Investing Activities

(12.8m)2.7m(182.0k)

Long-term Borrowings

49.7m

Cash From Financing Activities

46.9m9.0m(610.0k)

Net Change in Cash

5.2m(3.6m)(8.8m)

Elixinol Global Ratios

AUDFY, 2018

Elixinol Global Operating Metrics

H1, 2018FY, 2018H1, 2019

Countries (Customers)

404040

Facilities Owned (US), sq. ft.

20.7 k20.7 k20.7 k

Products

648888

Retailers

1 k